ici 204,219 has been researched along with Hepatitis B Virus Infection in 3 studies
zafirlukast: a leukotriene D4 receptor antagonist
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Zhao, S | 1 |
Zhen, Y | 1 |
Fu, L | 2 |
Gao, F | 1 |
Zhou, X | 1 |
Huang, S | 1 |
Zhang, L | 2 |
Chen, S | 1 |
Chen, Y | 1 |
Donkers, JM | 1 |
Zehnder, B | 1 |
van Westen, GJP | 1 |
Kwakkenbos, MJ | 1 |
IJzerman, AP | 1 |
Oude Elferink, RPJ | 1 |
Beuers, U | 1 |
Urban, S | 1 |
van de Graaf, SFJ | 1 |
1 review available for ici 204,219 and Hepatitis B Virus Infection
Article | Year |
---|---|
Inhibiting Sodium Taurocholate Cotransporting Polypeptide in HBV-Related Diseases: From Biological Function to Therapeutic Potential.
Topics: Carcinoma, Hepatocellular; Hep G2 Cells; Hepatitis B; Hepatitis B virus; Hepatocytes; Humans; Interf | 2022 |
2 other studies available for ici 204,219 and Hepatitis B Virus Infection
Article | Year |
---|---|
Design, synthesis and biological evaluation of benzamide derivatives as novel NTCP inhibitors that induce apoptosis in HepG2 cells.
Topics: Antineoplastic Agents; Antiviral Agents; Apoptosis; Benzamides; Drug Design; Hep G2 Cells; Hepatitis | 2019 |
Reduced hepatitis B and D viral entry using clinically applied drugs as novel inhibitors of the bile acid transporter NTCP.
Topics: Animals; Antiviral Agents; Dogs; Hepatitis B; Hepatitis B virus; Hepatitis D; Hepatitis Delta Virus; | 2017 |